Luma Group
Venture capitalNew York · Seed–Late Stage · 13 people tracked
Also known as LUMA GROUP ADVISOR LLC
Investment thesis
Osteoporosis represents a large, underserved chronic disease affecting millions of patients, with a critical gap in therapies that combine potency with long-term safety and durability. For decades, the field was constrained by expensive, lengthy fracture-endpoint clinical trials that discouraged innovation. The FDA's December 2025 decision to accept bone mineral density measured by DXA as a validated surrogate endpoint significantly reduces development time to 24 months and cost, enabling biotech and smaller companies to pursue novel bone-remodeling therapies. This regulatory reset, combined with deep unmet biology—the lack of durable anabolic agents suitable for chronic use—creates a tractable investment opportunity in next-generation bone health therapeutics.
Source: firm website, verified Aug 25, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 4 of 5 portfolio companiesBiotech ×3AI & Machine Learning ×2Consumer ×1Deep Tech ×1Digital Health ×1Fintech ×1Healthtech ×1Longevity ×1
HQs:United States×2United Kingdom×1
Investments · 5 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 14 dated
Apollo is a venture capital firm that invests in life-science and biotechnology startups, combining entrepreneurial expertise with deep scientific knowledge to support early-stage companies in drug development and personalized medicine.
BiotechDeep TechHealthtechLongevity
Nils Regge(Co-Founder & General Partner)in
Co-investorsBLN CapitalCoastCapFJ LabsKfW CapitalTruVenturo GmbHCTI Life Sciences Fund L.P.+3 more
Character Bio is a precision medicine company that integrates genomics, longitudinal clinical data, imaging, and AI-based biomarker analysis to identify genetic drivers of progressive polygenic eye diseases such as age-related macular degeneration and glaucoma.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(Executive Officer, Director)
BoardVivek Garipalli(Director)Nick Olsen(Director)Peter DiLaura(Director)
Co-investorsaMoonCantos VenturesCatalio Capital Management, LPDuke Capital PartnersLifeforce CapitalSanofi Ventures+3 more
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)Marie De Vulder(Chief Legal Officer Co-founder)Guy Peeters(Chief Financial Officer Co-founder)John-Paul Gallivan(Head of Development Co-founder)Fabrice Kolb(Head of Immunology Co-founder)Pieter Peeters(Operating & Technology Officer Co-founder)
Co-investorsLongwood FundSofinnova VenturesBAM ElevateFinchley Healthcare VenturesForbionNovo Holdings+1 more
Curve Pay is a digital wallet that combines multiple bank cards into one, letting users switch which card paid for a purchase after the fact, avoid foreign exchange fees, and earn cashback on top of existing card rewards.
ConsumerFintech
Shachar Bialick(Founder & CEO)
Co-investorsCohen CircleFuel Venture CapitalHanaco Venture CapitalLifeX VenturesMouro CapitalOutward VC+7 more
Platform using blood-based biomarkers and AI to detect and monitor chronic diseases like cirrhosis through organ-specific signals
Mountain View, US
CHUBA OYOLU(Executive Officer)NATHAN HUNKAPILLER(Executive Officer)SHAN XIANG WANG(Executive Officer, Director)RITISH PATNAIK(Executive Officer, Director)
BoardTHEMASAP KHAN(Director)in
Portfolio news
latest coverage across their companiesCurve · news.curve.finance · Aug 10, 2026
Coultreon · bioxconomy.com · Apr 29, 2026
Apollo Health Ventures · cen.acs.org · Apr 16, 2026
Character Bio · worldpharmaceuticals.net · Mar 26, 2025
Frequently asked questions
- What stage does Luma Group invest at?
- Luma Group invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Luma Group focus on?
- Luma Group focuses on Biotech, Healthtech, Medical Devices.
- Where is Luma Group located?
- Luma Group is headquartered in New York, US.
Media · Podcasts & interviews
from their channelDelivering on the Promise of Precision Medicine: A Conversation with Dr. Allison Hulme
Luma Group
AI, LABI, and How we Invest: A Conversation with Neel Madhukar, PhD and Themasap Khan, PhD
Luma Group
Reimagining Chronic Care: A Conversation with Ritish Patnaik of Curve Biosciences
Luma Group
The New Era of Multi-OMICs Therapy: A Conversation with Cheng Zhang
Luma Group
Inside the Golden Age of Biotech: A Conversation with Hans Bishop of Altos Labs
Luma Group
Images
Co-investors · 2
venBio is a life sciences venture capital firm that partners with industry leaders to develop novel therapeutics and technologies addressing unmet medical needs.
Apollo Health Ventures is a biotech-focused investor that combines traditional funding with venture building to back transformative healthcare and longevity companies in Europe and the US.
Firms observed investing alongside Luma Group, from public investor directories. Shared companies are the overlap with Luma Group's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.